01 8Janssen Inc.
02 16Purdue Pharma
03 1Blank
01 11222950
02 42264852
03 82355644
04 82355854
05 42515884
01 4Methylphenidate hydrochloride
02 20methylphenidate hydrochloride
03 1Blank
01 16Controlled-Release Capsule
02 8Extended Release Tablet
03 1Blank
01 12004-06-16
02 82017-09-16
03 162019-12-17
Patent Expiration Date : 2017-09-16
Date Granted : 2005-11-01
Brand Name : CONCERTA
Patent Number : 2264852
Filing Date : 1997-09-16
Strength per Unit : 18mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-09-16
Date Granted : 2005-11-01
Patent Expiration Date : 2017-09-16
Date Granted : 2005-11-01
Brand Name : CONCERTA
Patent Number : 2264852
Filing Date : 1997-09-16
Strength per Unit : 27mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-09-16
Date Granted : 2005-11-01
Patent Expiration Date : 2017-09-16
Date Granted : 2005-11-01
Brand Name : CONCERTA
Patent Number : 2264852
Filing Date : 1997-09-16
Strength per Unit : 36mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-09-16
Date Granted : 2005-11-01
Patent Expiration Date : 2017-09-16
Date Granted : 2005-11-01
Brand Name : CONCERTA
Patent Number : 2264852
Filing Date : 1997-09-16
Strength per Unit : 54mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-09-16
Date Granted : 2005-11-01
Patent Expiration Date : 2017-09-16
Date Granted : 2016-10-18
Brand Name : CONCERTA
Patent Number : 2515884
Filing Date : 1997-09-16
Strength per Unit : 18mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-09-16
Date Granted : 2016-10-18
Patent Expiration Date : 2017-09-16
Date Granted : 2016-10-18
Brand Name : CONCERTA
Patent Number : 2515884
Filing Date : 1997-09-16
Strength per Unit : 27mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-09-16
Date Granted : 2016-10-18
Patent Expiration Date : 2017-09-16
Date Granted : 2016-10-18
Brand Name : CONCERTA
Patent Number : 2515884
Filing Date : 1997-09-16
Strength per Unit : 36mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-09-16
Date Granted : 2016-10-18
Patent Expiration Date : 2017-09-16
Date Granted : 2016-10-18
Brand Name : CONCERTA
Patent Number : 2515884
Filing Date : 1997-09-16
Strength per Unit : 54mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-09-16
Date Granted : 2016-10-18
Patent Expiration Date : 2019-12-17
Date Granted : 2008-02-12
Brand Name : BIPHENTIN
Patent Number : 2355854
Filing Date : 1999-12-17
Strength per Unit : 50 mg
Dosage Form : Controlled-Release Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2019-12-17
Date Granted : 2008-02-12
Patent Expiration Date : 2019-12-17
Date Granted : 2008-02-12
Brand Name : BIPHENTIN
Patent Number : 2355854
Filing Date : 1999-12-17
Strength per Unit : 60 mg
Dosage Form : Controlled-Release Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2019-12-17
Date Granted : 2008-02-12
